BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Sunday, February 15, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 3, 2008
View Archived Issues
Almirall releases positive results for aclidinium bromide in the treatment of COPD
Read More
Boehringer Ingelheim launches direct thrombin inhibitor Pradaxa
Read More
Tekmira and Protiva enter share purchase agreement
Read More
Discovery Labs to meet with FDA to clarify items in approvable letter for Surfaxin in RDS
Read More
Gilead acquires Navitas' cicletanine for pulmonary arterial hypertension
Read More
Kiadis Pharma enters collaboration with Julius-Maximilians University for ATIR in GVHD
Read More
CureVac enters licensing agreement with LICR for three tumor-associated antigens
Read More
Medicines Company has announced results from VELOCITY phase III trial of Cleviprex
Read More
Repros Therapeutics releases findings from 1-year extension safety study of Proellex
Read More
Phase I study of seliciclib and Tarceva in advanced cancers scheduled to begin
Read More
PharmaIN and PNRI enter collaboration to study PGC GLP-1 in combination with Januvia
Read More
New agents for diabetes and other endocrine-related disorders reported in recent patents
Read More
New therapeutic agents for cardiovascular disorders disclosed in recent patent literature
Read More
Recent Janssen and Daiichi Sankyo patents impart novel antithrombotic agents
Read More
Early evidence of activity with ABT-263 in treating lymphoid malignancies
Read More
Atrium to initiate phase I clinical trial of Cinatra voclosporin coated coronary stent system
Read More
Patient death in phase I trial of StemCells' HuCNS-SC due to natural progression of disease
Read More
Kissei licenses KGT development and sales rights in Japan to GlaxoSmithKline
Read More
Enzon reports phase I results of EZN-2208 and EZN-2232
Read More
Pharmacopeia focuses resources on later-stage discovery programs
Read More
Phase III rivaroxaban trial shows superiority to enoxaparin in venous blood clots
Read More
Cardioprotective activity of novel adenosine 1 receptor agonist
Read More
Shareholders of CeNeS vote for acquisition by Paion
Read More
TransMolecular initiates phase I unlabeled TM-601 trial in malignant glioma
Read More
